Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 28, 2014; 20(24): 7707-7717
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7707
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7707
Generic Names | Brand Name | Manufacturer Name | Original approval or tentative approval date |
Interferon alpha-2b | Intron A | Schering | July, 1992 |
Pegylated interferon | Pegasys | Roche | 13-May-05 |
Lamivudine | Epivir-HBV | GlaxoSmithKline | 8-Dec-98 |
Adefovir dipivoxil | hepsera | Gilead sciences | 20-Sep-02 |
Entecavir | Baraclude | Bristol-myers squibb | 29-Mar-05 |
Telbivudine | Tyzeka | Novartis | 25-Oct-06 |
Tenofovir disoproxil fumarate | Viread | Gilead sciences | 8-Nov-08 |
- Citation: Wang XY, Chen HS. Emerging antivirals for the treatment of hepatitis B. World J Gastroenterol 2014; 20(24): 7707-7717
- URL: https://www.wjgnet.com/1007-9327/full/v20/i24/7707.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i24.7707